Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026

Balchem schedules Q3 2026 results release and conference call for October 23.

What the company is saying

Balchem Corporation is notifying investors and analysts that its third quarter 2026 financial results will be released before market open on Friday, October 23, 2026. The company will host a conference call at 11:00 AM Eastern Time the same day, led by Chairman, President and CEO Ted Harris and CFO Martin Bengtsson. The announcement emphasizes logistical details, including dial-in numbers for USA, Canada, and international participants, as well as a webcast link and replay availability for one year. The company highlights its three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. No commentary is provided on expected results, segment performance, or business outlook. The tone is strictly neutral and factual, with no forward-looking claims beyond the timing and availability of the results and call.

What the data suggests

The only hard facts disclosed are the timing and access details for the Q3 2026 results and conference call. No financial, operational, or segment performance data is included in this notice. The involvement of both the CEO and CFO signals that the call will be the primary venue for discussing results and answering questions. The replay will be accessible for one year, which is standard practice for public companies. The announcement confirms the company's ongoing structure and business focus but provides no insight into current financial health, trends, or risks. Investors will need to wait for the actual results release to assess performance, outlook, or any material changes.

Analysis

The announcement is a standard notice of an upcoming earnings conference call, providing logistical details and timing for the release of third quarter results. There is no promotional or exaggerated language, and no claims are made about financial or operational performance. The only forward-looking statements are factual (the call will occur, results will be published), and these are routine, near-term events. No capital outlay, strategic initiative, or benefit realization is discussed, and there is no attempt to frame the event as a value-creating milestone. The tone is strictly informational, with no evidence of narrative inflation or overstatement. All claims are either realised facts or imminent, routine disclosures.

Risk flags

• ●The absence of any preliminary financial or operational indicators in this notice means investors have no early visibility into Q3 performance, increasing the risk of a surprise—positive or negative—when results are released.
• ●The announcement does not preview any business challenges, segment shifts, or external factors that may have impacted results, leaving investors without context ahead of the call.
• ●Reliance on a single scheduled event for all material disclosures concentrates information risk into the results release date, which could lead to increased volatility if expectations are misaligned.

Bottom line

This announcement is purely logistical, giving investors the date, time, and access details for Balchem's Q3 2026 results and conference call. No financial or operational data is included, so investors cannot draw any conclusions about company performance or outlook from this notice alone. The presence of both the CEO and CFO on the call suggests that management will provide direct commentary and take questions on the results. Investors should be prepared for all material information to be released at once on October 23, with no advance guidance or context provided in this notice. The key takeaway is that the next actionable information will come with the Q3 results release and accompanying management discussion.

Announcement summary

(NASDAQ:BCPC) Balchem Corporation announced that it will hold a conference call on Friday, October 23, 2026, at 11:00 AM Eastern Time (ET) to review its third quarter results. The call will be hosted by Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO. Third quarter results will be published prior to the market opening on Friday, October 23, 2026. The press release and accompanying financial exhibits will be available on the company website, www.balchem.com, before the conference call. Institutional investors, analysts, and other members of the financial community are invited to join the live call by dialing +1-833-461-5787 (USA/Canada toll free) or +1-585-542-9983 (International Toll), and referencing Meeting ID: 831870284, five minutes prior to the scheduled start time. Investors and the public can listen to the live webcast at https://events.q4inc.com/attendee/831870284. The conference call will be available for replay shortly after the conclusion of the call at the same link for one year. Balchem Corporation develops, manufactures, and markets specialty ingredients for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to animal health markets. The Specialty Products segment provides specialty-packaged chemicals for healthcare and other industries, and chelated minerals to the micronutrient agricultural market.

Disagree with this article?